tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GSK Stock Latest News

GSK price target raised to 1,900 GBp from 1,780 GBp at Barclays
The FlyGSK price target raised to 1,900 GBp from 1,780 GBp at Barclays
3d ago
GSK
ViiV Healthcare says Cabenuva demonstrated superior efficacy in LATITUDE trial
PremiumThe Fly
ViiV Healthcare says Cabenuva demonstrated superior efficacy in LATITUDE trial
5d ago
GSK
PFE
FDA to begin requiring on clinical trial
PremiumThe Fly
FDA to begin requiring on clinical trial
5d ago
AZN
BMY
FDA to begin requiring one clinical trial in drug approvals
PremiumThe Fly
FDA to begin requiring one clinical trial in drug approvals
5d ago
AZN
BMY
GSK’s announces new data for Arexvy at RSVVW’26
PremiumThe Fly
GSK’s announces new data for Arexvy at RSVVW’26
6d ago
GSK
GSK’s Exdensur approved by European Commission for two indications
PremiumThe FlyGSK’s Exdensur approved by European Commission for two indications
6d ago
GSK
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
8d ago
J
W
GSK Advances Pediatric Antibiotic Strategy With New Gepotidacin Trial
Premium
Company Announcements
GSK Advances Pediatric Antibiotic Strategy With New Gepotidacin Trial
11d ago
GSK
GSK’s regulatory application for Arexvy accepted for review by China’s CDE
PremiumThe Fly
GSK’s regulatory application for Arexvy accepted for review by China’s CDE
13d ago
GSK
GSK price target raised to 2,250 GBp from 1,900 GBp at Citi
PremiumThe Fly
GSK price target raised to 2,250 GBp from 1,900 GBp at Citi
14d ago
GSK
GSK price target raised to 2,350 GBp from 2,100 GBp at BofA
PremiumThe Fly
GSK price target raised to 2,350 GBp from 2,100 GBp at BofA
14d ago
GSK
GSK price target raised to $70 from $55 at TD Cowen
PremiumThe Fly
GSK price target raised to $70 from $55 at TD Cowen
14d ago
GSK
Balancing Blenrep Upside With Valuation and Execution Risks: Why the Risk‑Reward Remains a Hold
PremiumRatingsBalancing Blenrep Upside With Valuation and Execution Risks: Why the Risk‑Reward Remains a Hold
14d ago
GSK
Balancing Strategic Promise and Execution Risk: Justifying a Hold Rating on GSK
Premium
Ratings
Balancing Strategic Promise and Execution Risk: Justifying a Hold Rating on GSK
14d ago
GSK
GSK Earnings Call: Specialty Strength Amid Vaccine Drags
Premium
Company Announcements
GSK Earnings Call: Specialty Strength Amid Vaccine Drags
15d ago
GSK
Trump Trade: Argentina says U.S. to cut hundreds of tariffs
PremiumThe Fly
Trump Trade: Argentina says U.S. to cut hundreds of tariffs
17d ago
BA
AZN
GSK announces European Commission approved Nucala
PremiumThe Fly
GSK announces European Commission approved Nucala
17d ago
GSK
TrumpRx website using technology from GoodRx, STAT says
PremiumThe Fly
TrumpRx website using technology from GoodRx, STAT says
18d ago
AZN
BMY
GSK’s H5N1 mRNA Flu Vaccine Trial Reaches Completion: What Investors Should Watch Next
PremiumCompany Announcements
GSK’s H5N1 mRNA Flu Vaccine Trial Reaches Completion: What Investors Should Watch Next
18d ago
GSK
Clear Street says AbbVie move further validates Oruka Therapeutics’ strategy
PremiumThe FlyClear Street says AbbVie move further validates Oruka Therapeutics’ strategy
19d ago
GSK
ABBV
GSK: Solid Near‑Term Delivery, Enhanced Shareholder Returns, and Compelling 2031 Growth Upside Support Buy Rating
Premium
Ratings
GSK: Solid Near‑Term Delivery, Enhanced Shareholder Returns, and Compelling 2031 Growth Upside Support Buy Rating
19d ago
GSK
Balancing Pipeline Upside and HIV Patent Cliff Risks: Justifying a Hold Rating Despite FX Drag and Valuation Richness
Premium
Ratings
Balancing Pipeline Upside and HIV Patent Cliff Risks: Justifying a Hold Rating Despite FX Drag and Valuation Richness
19d ago
GSK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >